MX9302191A - Metodo para sintetizar piruvil-glicina - Google Patents
Metodo para sintetizar piruvil-glicinaInfo
- Publication number
- MX9302191A MX9302191A MX9302191A MX9302191A MX9302191A MX 9302191 A MX9302191 A MX 9302191A MX 9302191 A MX9302191 A MX 9302191A MX 9302191 A MX9302191 A MX 9302191A MX 9302191 A MX9302191 A MX 9302191A
- Authority
- MX
- Mexico
- Prior art keywords
- pyruvil
- pyruvate
- glycine
- synthesizing
- mammal
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
Landscapes
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Obesity (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- General Chemical & Material Sciences (AREA)
- Child & Adolescent Psychology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
La presente invención describe un método para administrar piruvato, el método comprende administrar una cantidad terapéuticamente efectiva de un precursor de piruvato a un mamífero, en forma de piruvamida o un piruvil-amino ácido. El piruvilamino ácido se selecciona preferiblemente del grupo que comprende piruvil-glicina, piruvil-alanina, piruvil-leucina, piruvil-valina, piruvil-isoleucina, piruvil-fenilalanina, piruvil-prolina y piruvil-sarcosina, y sus amidas y ésteres, así como sus sales. Asociadas con la administración de un precursor de piruvato a un mamífero de acuerdo con esta invención están la resistencia aumentada a la insulina, menores niveles de insulina al ayunar, y aumento de grasa disminuido. También se describen métodos nuevos para sintetizar varios precursores de piruvato.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US07/868,891 US5256697A (en) | 1992-04-16 | 1992-04-16 | Method of administering pyruvate and methods of synthesizing pyruvate precursors |
Publications (1)
Publication Number | Publication Date |
---|---|
MX9302191A true MX9302191A (es) | 1994-03-31 |
Family
ID=25352516
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX9302191A MX9302191A (es) | 1992-04-16 | 1993-04-15 | Metodo para sintetizar piruvil-glicina |
Country Status (9)
Country | Link |
---|---|
US (4) | US5256697A (es) |
EP (1) | EP0636117B1 (es) |
JP (1) | JPH082854B2 (es) |
AU (1) | AU3659993A (es) |
CA (1) | CA2130198A1 (es) |
DE (1) | DE69325451T2 (es) |
ES (1) | ES2135468T3 (es) |
MX (1) | MX9302191A (es) |
WO (1) | WO1993021147A1 (es) |
Families Citing this family (32)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5256697A (en) * | 1992-04-16 | 1993-10-26 | Abbott Laboratories | Method of administering pyruvate and methods of synthesizing pyruvate precursors |
US5508308A (en) * | 1992-04-16 | 1996-04-16 | Abbott Laboratories | Use of pyruvylglycine to treat ischemia/reperfusion injury following myocardial infarction |
US5670539A (en) * | 1993-07-21 | 1997-09-23 | New York State Office Of Mental Health | Treatment of movement disorders using large neutral amino acids |
US5612374A (en) * | 1994-02-14 | 1997-03-18 | Ronald T. Stanko | Inhibiting growth of mammary adenocarcinoma |
US5480909A (en) * | 1994-08-08 | 1996-01-02 | University Of Pittsburgh Medical Center | Method for inhibiting generation of free-radicals |
US5550166A (en) * | 1995-03-17 | 1996-08-27 | Ostlund; Richard E. | Pinitol and derivatives thereof for the treatment of metabolic disorders |
US6306828B1 (en) | 1995-04-06 | 2001-10-23 | Baxter International, Inc. | Enantiomerically-enhanced nutritional energy substrates |
US5801198A (en) * | 1995-07-13 | 1998-09-01 | University Of Pittsburgh Medical Center | Retarding neutrophil infiltration ad morphologic reduction in ischemic bowel tissues |
EP0804181A4 (en) * | 1995-09-19 | 2005-02-02 | Cellular Sciences Inc | METHOD AND COMPOSITION FOR TREATING MAMMALIAN DISEASES CAUSED BY INFLAMMATORY REACTION |
US5798388A (en) * | 1996-09-06 | 1998-08-25 | Cellular Sciences, Inc. | Method and composition for treating mammalian diseases caused by inflammatory response |
US5876916A (en) * | 1996-03-18 | 1999-03-02 | Case Western Reserve University | Pyruvate compounds and methods for use thereof |
US6086789A (en) * | 1996-03-18 | 2000-07-11 | Case Western Reserve University | Medical uses of pyruvates |
US5667962A (en) * | 1996-03-18 | 1997-09-16 | Case Western Reserve University | Pyruvate thiolester for the prevention of reperfusion injury |
US5756469A (en) * | 1996-07-26 | 1998-05-26 | Beale; Paxton K. | Composition of pyruvate and anti-cortisol compounds and method for increasing protein concentration in a mammal |
US6008252A (en) * | 1996-07-26 | 1999-12-28 | Beale; Paxton K. | Method for increasing muscle mass in a mammal |
US5716926A (en) * | 1996-07-26 | 1998-02-10 | Paxton K. Beale | Composition of pyruvate and protein and method for increasing protein concentration in a mammal |
US6417231B1 (en) | 1996-12-23 | 2002-07-09 | Frank L. Greenway | Method and composition for delivering therapeutically effective amounts of pyruvate to a mammal |
JP2001514663A (ja) * | 1997-03-12 | 2001-09-11 | エスモンド,ロバート ダブリュー. | アルツハイマー病を処置または予防するための方法 |
US5886040A (en) * | 1997-06-17 | 1999-03-23 | Amt Labs, Inc. | Creatine pyruvate salt with enhanced palatability |
US20040058873A1 (en) * | 1998-03-12 | 2004-03-25 | Esmond Robert W. | Method for treating or preventing Alzheimer's disease |
WO2000071111A1 (en) | 1999-05-20 | 2000-11-30 | Humanetics Corporation | Stimulating transport of glucose into animal tissue by the administration of pinitol |
US6846842B2 (en) * | 1999-10-07 | 2005-01-25 | Beth Israel Deconess Medical Center, Inc. | Pyruvate ester composition and method of use for resuscitation after events of ischemia and reperfusion |
JP2004527501A (ja) | 2001-03-05 | 2004-09-09 | ピー. アーネスト,スティーヴン | 経腸処方 |
JP2004527529A (ja) * | 2001-04-04 | 2004-09-09 | クリティカル セラピューティックス インコーポレイテッド | 急性腎不全を予防するための方法 |
US6608196B2 (en) | 2001-05-03 | 2003-08-19 | Galileo Pharmaceuticals, Inc. | Process for solid supported synthesis of pyruvate-derived compounds |
US8076373B2 (en) * | 2001-09-11 | 2011-12-13 | North Cell Pharmacetical | Method for treating mammalian diseases and injuries caused by the over-expression of peroxynitrite |
EP1494659B1 (en) * | 2002-04-17 | 2005-10-12 | Critical Therapeutics, Inc. | Pharmaceutical composition comprising an alpha-ketoalkanoic acid ester or -amide and lactic acid or a lactic acid salt |
US7273616B2 (en) * | 2002-05-10 | 2007-09-25 | The Trustees Of Columbia University In The City Of New York | Genetically engineered cell lines and systems for propagating Varicella zoster virus and methods of use thereof |
EP1807069B1 (en) * | 2004-11-02 | 2017-03-22 | Oragenics, Inc. | Methods for regulating weight and size of animals with glycine |
AU2010276259B2 (en) * | 2009-07-21 | 2013-04-18 | Hill's Pet Nutrition, Inc. | Companion animal nutrition system |
US8450090B2 (en) | 2009-10-06 | 2013-05-28 | The Regents Of The University Of Colorado, A Body Corporate | Compositions and methods for promoting fatty acid production in plants |
EP2519115B1 (en) * | 2009-12-29 | 2017-02-15 | Hill's Pet Nutrition, Inc. | Compositions including pyruvate for companion animals and methods of use thereof |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SE372006B (es) * | 1971-09-13 | 1974-12-09 | Haessle Ab | |
US4197316A (en) * | 1975-07-23 | 1980-04-08 | Scott Eugene J Van | Treatment of dry skin |
US4296127A (en) * | 1979-04-18 | 1981-10-20 | The Johns Hopkins University | Mixed salts of essential or semi-essential amino acids and nitrogen-free analogs thereof |
IT1120033B (it) * | 1979-10-05 | 1986-03-19 | Sigma Tau Ind Farmaceuti | Composizione farmaceutica comprendente-carnitina adatta per l'alimentazione parenterale |
US4548937A (en) * | 1981-04-01 | 1985-10-22 | Montefiore Hospital | Method for preventing body fat deposition in mammals |
US4351835A (en) * | 1981-04-01 | 1982-09-28 | Montefiore Hospital | Method for preventing body fat deposition in mammals |
DE3438455A1 (de) * | 1984-10-19 | 1986-06-26 | Institut Dr. Ziegler, Bettingen | L-lysin- und l-histidinpyruvat |
FR2626276B1 (fr) * | 1988-01-22 | 1990-05-11 | Hoechst France | Perfectionnement au procede de fabrication de pyruvates d'alkyle |
US4874790A (en) * | 1988-08-15 | 1989-10-17 | Montefiore Hospital Association Of Western Pennsylvania | Method for improving the glucose metabolism of an animal having diabetic tendencies |
DE3917880A1 (de) * | 1989-06-01 | 1990-12-06 | Kali Chemie Ag | Neue acylaminosaeurederivate enthaltende arzneimittel und diaetetika |
US5256697A (en) * | 1992-04-16 | 1993-10-26 | Abbott Laboratories | Method of administering pyruvate and methods of synthesizing pyruvate precursors |
-
1992
- 1992-04-16 US US07/868,891 patent/US5256697A/en not_active Expired - Fee Related
-
1993
- 1993-02-09 EP EP93905827A patent/EP0636117B1/en not_active Expired - Lifetime
- 1993-02-09 DE DE69325451T patent/DE69325451T2/de not_active Expired - Fee Related
- 1993-02-09 CA CA002130198A patent/CA2130198A1/en not_active Abandoned
- 1993-02-09 ES ES93905827T patent/ES2135468T3/es not_active Expired - Lifetime
- 1993-02-09 WO PCT/US1993/001134 patent/WO1993021147A1/en active IP Right Grant
- 1993-02-09 JP JP5518291A patent/JPH082854B2/ja not_active Expired - Lifetime
- 1993-02-09 AU AU36599/93A patent/AU3659993A/en not_active Abandoned
- 1993-04-08 US US08/043,699 patent/US5312985A/en not_active Expired - Fee Related
- 1993-04-08 US US08/043,720 patent/US5283260A/en not_active Expired - Fee Related
- 1993-04-15 MX MX9302191A patent/MX9302191A/es unknown
-
1994
- 1994-08-04 US US08/285,683 patent/US5472980A/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
US5312985A (en) | 1994-05-17 |
DE69325451T2 (de) | 2000-01-20 |
EP0636117A4 (en) | 1995-07-26 |
US5256697A (en) | 1993-10-26 |
US5283260A (en) | 1994-02-01 |
ES2135468T3 (es) | 1999-11-01 |
DE69325451D1 (de) | 1999-07-29 |
AU3659993A (en) | 1993-11-18 |
JPH07501830A (ja) | 1995-02-23 |
EP0636117B1 (en) | 1999-06-23 |
EP0636117A1 (en) | 1995-02-01 |
CA2130198A1 (en) | 1993-10-28 |
JPH082854B2 (ja) | 1996-01-17 |
WO1993021147A1 (en) | 1993-10-28 |
US5472980A (en) | 1995-12-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX9302191A (es) | Metodo para sintetizar piruvil-glicina | |
NO20071498L (no) | Substituerte acylhydroksamsyrer samt fremgangsmate for a redusere TNFa-nivaet | |
ES2150663T3 (es) | Tratamiento de la incontinencia urinaria utilizando (s)-oxibutinina y (s)-desetiloxibutinina. | |
AR246755A1 (es) | Una composicion para el tratamiento de las superficies de los suelos. | |
RU93005334A (ru) | Производные стероидов для лечения гипертрофии предстательной железы, способ их получения, использование, фармкомпозиция | |
AT305262B (de) | Verfahren zur Herstellung neuer, linksdrehender, basisch substituierter Phenylacetonitrile sowie deren Salze | |
MX167912B (es) | Metodo para la produccion de una preparacion de nicorandil estable | |
DK0451654T3 (da) | Anvendelse af N-alkylerede 1,4-dihydropyridin-dicarboxylsyreestere som lægemidler, nye forbindelser og fremgangsmåder til deres fremstilling | |
GB1394416A (en) | Cyclopropanecarboxylates processes for producing them and compositions containing them | |
SE9601677D0 (sv) | New use | |
SE9300758D0 (sv) | Process for the production of clavulanic acid | |
ES385523A1 (es) | Procedimiento para la preparacion de compuestos farmacolo- gicamente activos de esteres de acido antranilico. | |
AT305263B (de) | Verfahren zur Herstellung neuer, rechtsdrehender, basisch substituierter Phenylacetonitrile sowie deren Salze | |
FR2354999A1 (fr) | Nouvel ester de p-hydroxyphenyluree de l'ibuprofene et son procede de preparation | |
AR034398A1 (es) | Homologos de 15-hete con 3-heteroatomos sustituidos y dos atomos de carbono del acido hidroxieicosatetraenoico, composicion que los contiene y el uso de la misma para la manufactura de un medicamento | |
GB1272915A (en) | Treatment and prevention of scours in livestock | |
FR2336369A1 (fr) | Procede d'obtention d'acide glutarique, d'acide succinique et d'acide adipique a partir d'un melange acide les contenant ainsi que lesdits acides obtenus par ce procede | |
DE59203777D1 (en) | Aminomethylencyanessigsäureester und -amide. | |
AT278508B (de) | Verfahren zur Herstellung von Matratzen od.dgl. sowie nach diesem Verfahren hergestellte Matratze | |
ES2031462T3 (es) | Procedimiento para producir 1-b-d-arabinofuranosilcitosina-5'-estearilfosfato monosodico y monohidrato de la misma, y compuesto farmaceutico que contiene esta ultima. | |
CH490379A (de) | Verfahren zur Herstellung eines Cyclopropancarbonsäureesters sowie Verwendung des nach dem Verfahren hergestellten Cyclopropancarbonsäureesters | |
AT318568B (de) | Verfahren zur Herstellung neuer 1-Phenoxy-2-hydroxy-3-hydroxyalkylaminopropane sowie deren Säureadditionssalze und Ester | |
AT289752B (de) | Verfahren zur Herstellung von neuen 4-Aminomethylbicyclo[2,2,2]octan- bzw. 4-Aminomethylbicyclo[3,2,2]nonan-1-carbonsäuren und deren 2,5-Diketoverbindungen, sowie deren Salzen, Estern und N-Alkanoylverbindungen | |
CH514571A (fr) | Procédé de préparation d'esters d'acides cyclopropane-carboxyliques | |
AT291739B (de) | Verfahren zur Herstellung von Metallfasern enthaltenden Bahnen sowie nach diesem Verfahren hergestellte, Metallfasern enthaltende Bahn |